Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Indikationer for radioimmunterapi til patienter med non-Hodgkins lymfom

Publication: ResearchJournal article

  1. Bursitis efter vaccination i skulderregionen

    Publication: Research - peer-reviewJournal article

  2. Bandager til Knælidelser

    Publication: Research - peer-reviewJournal article

  3. Fast-track totalknæalloplastik

    Publication: Research - peer-reviewJournal article

  4. Profylaktisk brug af antibiotika ved herniekirurgi

    Publication: Research - peer-reviewJournal article

View graph of relations
Translated title of the contributionIndications for radioimmunotherapy for patients with non-Hodgkin's lymphoma
Radioimmunotherapy is a well-known treatment for non-Hodgkin's lymphoma. (90)yttrium (Y)-ibritumomab-tiuxetan consists of a radioisotope conjugated to a monoclonal anti-cluster of differentiation 20 antibody, which is targeted against B-lymphocytes. Initially the treatment indication was relapse of low-grade non-Hodgkin's lymphoma. However, (90)Y-ibritumomab-tiuxetan has later been used in clinical trials in the treatment of other types of non-Hodgkin's lymphoma and prior to stem cell transplantation. Based on the literature this systematic review aims to throw light on the future possibilities of radioimmunotherapy.
Original languageDanish
JournalUgeskrift for Laeger
Volume173
Issue number20
Pages (from-to)1417-21
Number of pages5
ISSN0041-5782
StatePublished - 2011

ID: 34579273